Glaukos Corporation announced that the US Centers for Medicare and Medicaid Services (CMS) has assigned a permanent ...
Gabriel discusses a robotic femtosecond laser platform for LASIK, focusing on flap accuracy, stromal bed precision, and the ...
On March 9, 2026, SpyGlass Pharma announced positive 12-month results from its phase 1/2 trial of the Bimatoprost Drug ...
The management of dry eye disease may benefit from earlier intervention, according to data presented by Eric D. Donnenfeld, ...
For cataract surgeons, the conversation around phacoemulsification is increasingly shifting from ultrasound power to fluidics ...
Uncorrected acuity at 36 months showed continuous range: monocular 20/20 distance and intermediate, 20/27 near; binocular ...
New 52-week analyses from the phase 3 SOL-1 trial suggest that the investigational intravitreal therapy AXPAXLI (OTX-TKI) may ...
Evidence gaps include limited topline safety granularity, unknown long-term follow-up and retreatment rates, and lack of ...
The FDA’s decision to extend the labeled duration of faricimab use in RVO beyond 6 months primarily reflects accumulated ...
As expectations for refractive cataract surgery continue to rise, preoperative ocular surface optimization remains essential ...
Tran, MD, compared refractive accuracy, cylinder correction, and postoperative adjustment rates between femtosecond ...
An ophthalmology resident shares insights from experiences across Mexico, Europe, and the US.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results